I don't understand enough about the DSMB's interim review, from which they recommended continuing the trial unchanged.
Is the data they reviewed available to Durrant, and would that be the data he used for an EUA?
I know that going for an EUA when Phase III data analysis may be available in 4 - 6 weeks may suggest just waiting. But beating Lily and the other developing contenders would be worth going for the EUA, in my opinion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.